News
Tagrisso-chemo cleared in US as 1st-line lung cancer therapy
AstraZeneca’s Tagrisso can be used alongside chemotherapy as a frontline therapy for EGFR-positive non-small cell lung cancer (NSCLC), according to the FDA, consolidating
